Dr Ceri Morgan is a Partner at Dalloway Partners, the advisory firm founded in 2025 by Vanessa Colomar and Helen James to help foundational science and first-time founders scale at speed. A medical doctor by training, she practised in cardiology and trauma medicine before moving into the City, where she spent more than two decades in healthcare and life sciences investment banking at firms including KBC Peel Hunt and Deutsche Bank, advising companies such as Oxford Nanopore and IP Group.

Most recently she was Head of Late Stage Portfolio at Oxford Science Enterprises, and she is a Senior Advisor to LifeScience ORG. She also sits on a London hospital patient advisory group, drawing on her own experience as a cancer patient.